Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy

Published:2024-06 Issue:6 Volume:32 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Yang Ciqiu,Li Peiyong,Chen Yitian,Zheng Junqiu,Zhang Xiaoqi,Gao Hong-Fei,Zhang Liulu,Wang Kun^ORCID

Funder

Beijing Life Oasis public Service Center

2021 National nature project start-up supporting funds

National Natural Science Foundation of China

Deng Feng project of high-level hospital construction

Guangdong Basic and Applied Basic Research Foundation

Guangzhou Science and Technology Project

Macao Science and Technology Development Fund

Beijing Medical Award Foundation

Beijing Science and Technology Innovation Medical Development Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00520-024-08610-3.pdf

Reference50 articles.

1. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981–1988. https://doi.org/10.1161/CIRCULATIONAHA.114.013777

2. Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. New England J Med 339:900–905. https://doi.org/10.1056/NEJM199809243391307

3. Poggio F, Bruzzone M, Ceppi M, Pondé NF, La Valle G, Del Mastro L et al (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29:1497–1508. https://doi.org/10.1093/annonc/mdy127

4. Villacampa G, Matikas A, Oliveira M, Prat A, Pascual T, Papakonstantinou A (2023) Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis. European J Cancer 2023:112885. https://doi.org/10.1016/j.ejca.2023.03.042

5. Gao H-F, Wu Z, Lin Y, Song X-Y, Cao Y, Chen Q-J et al (2021) Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial. Ther Adv Med Oncol 13:175883592110090. https://doi.org/10.1177/17588359211009003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Arrhythmia Risk after Anti-Cancer Drug Exposure and Related Disease Molecular Imaging Outlook: A Systematic Review, Meta-Analysis, and Network Meta-Analysis;Biology;2024-06-25